Retinal(CAS: 116-31-4)

Retinal (CAS: 116-31-4) is regulated under the Globally Harmonized System of Classification and Labeling of Chemicals (GHS) as a Category 3 sensitizer. In the European Union, Retinal falls under the Registration, Evaluation, Authorization, and Restriction of Chemicals (REACH) regulations. Additionally, the U.S. Food and Drug Administration (FDA) and Environmental Protection Agency (EPA) have specific requirements for the handling and use of Retinal in pharmaceutical and industrial applications.

Alternatives to Retinal (CAS: 116-31-4) in synthesis include related retinoids such as all-trans retinoic acid and 9-cis retinoic acid. These can be used as substitutes in various chemical reactions due to their similar structural characteristics and reactivity. Other common reagents like β-ionone can also serve as alternatives depending on the specific application.

The market for Retinal (CAS: 116-31-4) is driven by its applications in pharmaceuticals, particularly in ophthalmology for treating retinal disorders. Research trends focus on understanding its role in vision and its potential in gene therapy and neurodegenerative diseases. The market is expected to grow due to increasing demand and novel therapeutic applications.

Waste containing Retinal (CAS: 116-31-4) should be collected in appropriate containers and disposed of through professional waste disposal services. Incineration may be necessary for complete destruction. Environmental precautions include minimizing exposure and ensuring the waste is not released into the environment. Compliance with local and international regulations is essential to ensure safe handling and disposal.